KMB

Business Context and Reporting Period

Company: Kimberly-Clark Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2008
Business Overview: The Corporation operates four global business segments: Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care. It manufactures and markets disposable diapers, tissue products, professional hygiene products, and medical supplies.

Key Financial Metrics

Note: Total Debt calculated as Debt payable within one year ($1,282.4) plus Long-Term Debt ($4,442.6).

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 9.7% year-over-year, driven by a 3% volume increase, 2% price increase, favorable product mix (1%), and favorable currency effects (4%).
• Profitability: Operating profit rose 7.8% to $664.1 million. However, Net Income declined 2.5% to $440.9 million. The decline in net income was primarily due to a higher effective tax rate (27.5% in 2008 vs. 20.6% in 2007) and increased interest expense ($24 million higher) related to debt issued for share repurchases.
• Segment Performance:
  • Personal Care: Sales up 13.8%; Operating profit up 23.3%.
  • Consumer Tissue: Sales up 7.1%; Operating profit down 24.9% due to raw material and energy cost inflation.
  • Health Care: Sales down 1.6%; Operating profit down 16.9% due to competitive conditions and lower demand for face masks.
• Cost Reductions: Pretax charges for the strategic cost reduction plan decreased to $23.8 million in Q1 2008 from $40.6 million in Q1 2007.
• Working Capital: Cash flow from operations decreased by $80.4 million, primarily due to a $230.9 million increase in operating working capital, largely driven by inventory buildup.

Guidance, Outlook, and Risks

• Outlook: Management expects solid organic sales growth for the remainder of 2008. Favorable currency effects are anticipated to continue benefiting sales comparisons.
• Margin Pressure: The Corporation anticipates continued inflationary pressure on margins, specifically citing recent increases in fiber and oil costs.
• Capital Allocation:
  • Share Repurchases: The company repurchased approximately 3.1 million shares for ~$200 million in Q1 2008. The target for 2008 is $800 million to $1 billion.
  • Capital Spending: Q1 spending was $221.1 million. Full-year 2008 guidance remains $850 million to $950 million.
• Strategic Cost Reduction Plan: The plan is in its final stages. Cumulative charges incurred to date are approximately $844 million (95% of the expected $880-$910 million total). The plan aims for a net workforce reduction of ~10% (6,000 employees).
• Legal/Environmental:
  • Delcora Dispute: Ongoing litigation regarding alleged underreporting of effluent discharge at the Chester Mill. Management does not expect a material adverse effect.
  • Washington State Settlement: Settled a violation regarding smoke/odor from a wood waste pile for a total of $165,000 ($40k penalty + $125k to clean air agency).

Investor Verification Checklist

• Inventory Levels: Verify the rationale for the significant increase in inventory ($168.8 million increase QoQ) and its impact on future working capital cash flow.
• Raw Material Costs: Monitor the trajectory of fiber and oil prices, as management explicitly flagged these as primary drivers of margin compression.
• Health Care Segment: Assess the sustainability of the decline in the Health Care segment, particularly regarding the recovery of face mask demand post-avian flu concerns.
• Debt Service: Review the impact of the $2 billion debt issuance (for the Accelerated Share Repurchase) on future interest expense and liquidity.
• Cost Reduction Savings: Track the realization of the targeted $75-$100 million in annual cost savings from the strategic cost reduction plan.